• Mashup Score: 2

    The need for serial in-office nonstress tests (NSTs) adds substantial burden to high-risk pregnancies and exacerbates care disparities.1,2 INVU by Nuvo Group, Ltd, is a novel Food and Drug Administration-cleared, remote, self-administered maternal-fetal monitoring solution, previously validated for fetal and maternal heart rates and uterine activity measurements.3–5 Here, we sought to determine the clinical interpretability and usability of INVU to enable patients to perform NSTs from home.

    Tweet Tweets with this article
    • RT @cem_baykal: 👇 https://t.co/vpHtjqbl0V

  • Mashup Score: 2

    The impact of infections and inflammation during pregnancy on the developing fetal brain remains incompletely defined, with important clinical and research gaps. Although the classic infectious TORCH pathogens (ie, Toxoplasma gondii, rubella virus, cytomegalovirus [CMV], herpes simplex virus) are known to be directly teratogenic, emerging evidence suggests that these infections represent the most extreme end of a much larger spectrum of injury. We present the accumulating evidence that prenatal exposure to a wide variety of viral and bacterial infections—or simply inflammation—may subtly alter fetal brain development, leading to neuropsychiatric consequences for the child later in life.

    Tweet Tweets with this article
    • RT @AJOG_thegray: AJOG Expert Review: The fetal origins of mental illness https://t.co/Bh8J4GbCeZ https://t.co/4yhmyDWdyy